Gale Eric M, Caravan Peter, Rao Anil G, McDonald Robert J, Winfeld Matthew, Fleck Robert J, Gee Michael S
Department of Radiology, The Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.
Pediatr Radiol. 2017 May;47(5):507-521. doi: 10.1007/s00247-017-3806-0. Epub 2017 Apr 13.
Gadolinium-based contrast agents can increase the accuracy and expediency of an MRI examination. However the benefits of a contrast-enhanced scan must be carefully weighed against the well-documented risks associated with administration of exogenous contrast media. The purpose of this review is to discuss commercially available gadolinium-based contrast agents (GBCAs) in the context of pediatric radiology. We discuss the chemistry, regulatory status, safety and clinical applications, with particular emphasis on imaging of the blood vessels, heart, hepatobiliary tree and central nervous system. We also discuss non-GBCA MRI contrast agents that are less frequently used or not commercially available.
基于钆的造影剂可以提高MRI检查的准确性和效率。然而,必须仔细权衡增强扫描的益处与外源性造影剂给药所带来的诸多已被充分记录的风险。本综述的目的是在儿科放射学背景下讨论市售的基于钆的造影剂(GBCA)。我们讨论其化学性质、监管状况、安全性及临床应用,尤其着重于血管、心脏、肝胆系统和中枢神经系统的成像。我们还将讨论较少使用或未上市的非GBCA MRI造影剂。